Torrent Pharma

Torrent Pharma, founded in 1971, is the flagship enterprise of the Torrent Group and a prominent leader in the Indian pharmaceutical sector. The company specializes in diverse therapeutic areas, including cardiovascular health, central nervous system disorders, gastro-intestinal care, and cosmo-dermatology. By prioritizing scientific excellence, the firm maintains a robust portfolio that also encompasses diabetology, pain management, oncology, and anti-infective treatments, ensuring high-quality, affordable healthcare solutions for patients globally.

Operating with a workforce of over 10,000 employees, Torrent Pharma leverages advanced infrastructure to drive its research and development initiatives. The company maintains 10 strategic locations, supporting its mission to deliver innovative medical products. Its commitment to R&D is evidenced by a large scientific workforce focused on developing complex formulations and high-quality medicines that meet international regulatory standards. This operational scale allows the organization to maintain a competitive edge in both domestic and international markets.

With a significant international footprint, Torrent Pharma continues to expand its influence across various global regions. The company’s strategic focus on innovation and quality control has solidified its reputation as a reliable partner in the healthcare industry. Meet Torrent Pharma's team to learn about the leadership and organizational structure driving these advancements. Through its dedication to patient-centric care and continuous improvement, the company remains a key player in the global pharmaceutical landscape, consistently delivering value through its extensive product pipeline and commitment to medical excellence.